Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Harris

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
The Journal of Clinical Investigation|August 15, 2018
Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host diseaseDongchang Zhao, Yeung-Hyen Kim, Seihwan Jeong, et al.
The Lancet. Oncology|October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.
Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.
The Lancet. Haematology|December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 studyMichael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
Blood Advances|October 11, 2022
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoffrey D E Cuvelier, Bernard Ng, Sayeh Abdossamadi, et al.
Blood|September 17, 2021
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host diseaseDivya Subburaj, Bernard Ng, Amina Kariminia, et al.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Transplantation and Cellular Therapy|April 7, 2024
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated ToxicitiesTakuto Takahashi, Benjamin Watkins, Brandi Bratrude, et al.
The Journal of Clinical Investigation|August 15, 2018
Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host diseaseDongchang Zhao, Yeung-Hyen Kim, Seihwan Jeong, et al.
The Lancet. Oncology|October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.
Blood|June 15, 2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, et al.
The Lancet. Haematology|December 3, 2025
Model-based antithymocyte globulin dosing in ex vivo CD34+ selected allogeneic haematopoietic cell transplantation: a single-centre, single-arm, phase 2 studyMichael Scordo, Miguel-Angel Perales, Audrey Mauguen, et al.
Blood Advances|October 11, 2022
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoffrey D E Cuvelier, Bernard Ng, Sayeh Abdossamadi, et al.
Blood|September 17, 2021
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host diseaseDivya Subburaj, Bernard Ng, Amina Kariminia, et al.
Blood|May 3, 2019
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoffrey D E Cuvelier, Eneida R Nemecek, Justin T Wahlstrom, et al.
JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.
Pageof 10